ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer

Chen, Hongxia; Li, Hongying*; Wang, Lei*; Li, Yaxiong; Yang, ChunYanhubei univ sci & technol; wuhan univ sci & technol; maternal & child hlth hosp hubei prov; hubei univ chinese med
JOURNAL OF OBSTETRICS AND GYNAECOLOGY2022-2-17DOI: 10.1080/01443615.2021.1907563
3被引15阅读
引用收藏
分享

摘要

The demographic information and overall survival (OS) of patients with cervical cancer (CC) (pathological stage: IA-IIA) were extracted from the TCGA database. A univariate and multivariate Cox proportional hazard model was performed to identify methylation markers significantly associated with the OS of patients in the training dataset. Then such a prognostic classifier was tested on the validation set and all subgroups. The Kaplan-Meier analysis and ROC analysis were performed to detect the ability to discriminate between patients with different risks and different OS. A DNA methylation signature which contained five genes was found to be significantly associated with the OS of CC patients by the Cox regression analysis in the training dataset. Such a signature could efficiently distinguish the patients into two risk groups with significantly different OS in both datasets. The receiver operating characteristic (ROC) analysis showed it had high sensitivity and specificity. Moreover, such a prognostic model also could be effectively applied to different subgroups, including groups of different ages, tumour sizes, histologic types, etc. A 5-DNA methylation signature identified by this study may act as a novel prognostic indicator for early-stage CC, and it may be helpful for the timely diagnosis and intervention of CC at pathological stages IA-IIA.Impact Statement What is already known on this subject? Cervical cancer (CC) is one of the most common gynaecological malignant tumours. What the results of this study add? This study constructed a risk model based on a 5-DNA methylation signature for early-stage CC patients' survival prediction. What the implications are of these findings for clinical practice and/or further research? Methylated markers have the potential to discriminate patients of different risks and different OS. Our results may shed new light on the early diagnosis and intervention, and potential therapeutic targets for CC patients at pathological stages IA-IIA.

学科与关键词

关键词
Cervical cancerDNA methylationrisk scoreoverall survival
相关
加载中…
  • Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations
    Liu, Wenxin*; Jiang, Qiuying; Sun, Chao; Liu, ShiHao; Zhao, Zhikun; Wu, DongfangBMC CANCER, 2022, 22(1): 192.被引 2
  • Identification and verification of a 4-gene signature predicting the overall survival of cervical cancer
    Yuan, Lu; Lu, Zijun; Sun, Guoqiang*; Cao, Dongmei*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(42): e31299.
  • DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management
    Xianxiong Ma; Jiancheng Cheng; Peng Zhao; Lei Li; Kaixiong Tao; Hengyu ChenJournal of Cellular and Molecular Medicine, 2020, 24(13): 7576-7589.
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF OBSTETRICS AND GYNAECOLOGY
发表日期
2022-02-17
卷期
第 42 卷, 第 2 期
页码
327-332
DOI
10.1080/01443615.2021.1907563
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Health Commission of Hubei Province Scientific Research Project [WJ2019H188]; Special Research Project of Key Discipline of Pharmacy of Hubei University of Science and Technology [2019-20YZ02]

作者

  • C

    Chen, Hongxia (第一作者)

    hubei univ sci & technol

  • L

    Li, Hongying (通讯)

    wuhan univ sci & technol · maternal & child hlth hosp hubei prov

查看全部 5 位作者收起作者
  • W

    Wang, Lei (通讯)

    hubei univ chinese med

  • L

    Li, Yaxiong

    hubei univ sci & technol

  • Y

    Yang, ChunYan

    hubei univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417